ADVFN Logo
Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
191.68
0.85
(0.45%)
Closed July 15 4:00PM
191.68
0.00
( 0.00% )
Pre Market: 4:09AM

Professional-Grade Tools, for Individual Investors.

Key stats and details

Current Price
191.68
Bid
-
Ask
-
Volume
-
0.00 Day's Range 0.00
170.59 52 Week Range 319.67
Market Cap
Previous Close
191.68
Open
-
Last Trade
Last Trade Time
-
Financial Volume
-
VWAP
-
Average Volume (3m)
336,307
Shares Outstanding
38,764,917
Dividend Yield
-
PE Ratio
81.69
Earnings Per Share (EPS)
2.35
Revenue
1.06B
Net Profit
90.95M

About Penumbra Inc

Penumbra Inc develops and manufactures medical devices for the neurovascular and peripheral vascular markets. Its products are primarily sold to hospitals and are developed for use by specialist physicians. The neurovascular product category contributes to the majority of revenue. Within the neurova... Penumbra Inc develops and manufactures medical devices for the neurovascular and peripheral vascular markets. Its products are primarily sold to hospitals and are developed for use by specialist physicians. The neurovascular product category contributes to the majority of revenue. Within the neurovascular business, the firm offers products for the neurovascular access, ischemic stroke, neurovascular embolization, and neurosurgical tool markets. In the peripheral vascular business, the firm sells devices related to peripheral embolization and peripheral thrombectomy. Penumbra generates the majority of its revenue in the United States. Show more

Sector
Surgical,med Instr,apparatus
Industry
Surgical,med Instr,apparatus
Headquarters
Dover, Delaware, USA
Founded
1970
Penumbra Inc is listed in the Surgical,med Instr,apparatus sector of the New York Stock Exchange with ticker PEN. The last closing price for Penumbra was $191.68. Over the last year, Penumbra shares have traded in a share price range of $ 170.59 to $ 319.67.

Penumbra currently has 38,764,917 shares outstanding. The market capitalization of Penumbra is $7.43 billion. Penumbra has a price to earnings ratio (PE ratio) of 81.69.

Penumbra (PEN) Options Flow Summary

Overall Flow

Bearish

Net Premium

-614k

Calls / Puts

16.67%

Buys / Sells

0.00%

OTM / ITM

100.00%

Sweeps Ratio

0.14%

PEN Latest News

Penumbra, Inc. Schedules Second Quarter 2024 Earnings Release and Conference Call for July 30, 2024

Penumbra, Inc. Schedules Second Quarter 2024 Earnings Release and Conference Call for July 30, 2024 PR Newswire ALAMEDA, Calif., July 2, 2024 ALAMEDA, Calif., July 2, 2024 /PRNewswire/...

Penumbra, Inc. to Present at the Truist Securities MedTech Conference

Penumbra, Inc. to Present at the Truist Securities MedTech Conference PR Newswire ALAMEDA, Calif., June 4, 2024 ALAMEDA, Calif., June 4, 2024 /PRNewswire/ -- Penumbra, Inc. (NYSE: PEN) today...

Penumbra, Inc. to Present at the William Blair Growth Stock Conference

Penumbra, Inc. to Present at the William Blair Growth Stock Conference PR Newswire ALAMEDA, Calif., May 23, 2024 ALAMEDA, Calif., May 23, 2024 /PRNewswire/ -- Penumbra, Inc. (NYSE: PEN) today...

PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
112.316.86290907064179.37194.58174.5354347186.14159417CS
45.753.09256171678185.93194.58170.59335537179.36331167CS
12-12.22-5.99313388916203.9220.4075170.59336307192.92521808CS
26-63.2-24.7959824231254.88277.34170.59334760217.11055218CS
52-123.58-39.1993909789315.26319.67170.59369625230.40717191CS
156-60.82-24.0871287129252.5348.67114.865316209225.80325052CS
26019.0811.0544611819172.6348.67107.5356923212.90119165CS

Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
CDTConduit Pharmaceuticals Inc
$ 0.415
(72.92%)
22.34M
WNWMeiwu Technology Company Ltd
$ 1.26
(41.57%)
3.9M
SPRCSciSparc Ltd
$ 1.15
(40.24%)
1.05M
SYRASyra Health Corporation
$ 1.75
(31.09%)
1
WINTWindtree Therapeutics Inc
$ 4.50
(21.62%)
10
GRNQGreenpro Capital Corporation
$ 0.9204
(-22.00%)
101.01k
AMIXAutonomix Medical Inc
$ 1.11
(-19.57%)
488.22k
CMNDClearmind Medicine Inc
$ 1.80
(-18.92%)
244.27k
TANHTantech Holdings Ltd
$ 0.50
(-18.18%)
1.19M
TCTuanChe Ltd
$ 1.38
(-15.85%)
353.88k
CDTConduit Pharmaceuticals Inc
$ 0.417
(73.75%)
22.22M
KRKR36Kr Holdings Inc
$ 0.302
(1.62%)
4.98M
WNWMeiwu Technology Company Ltd
$ 1.31
(47.19%)
3.74M
SLNASelina Hospitality PLC
$ 0.0664
(6.07%)
2.55M
MAXNMaxeon Solar Technologies Ltd
$ 0.2183
(-3.83%)
1.65M

PEN Discussion

View Posts
@LaughinPaulRyan @LaughinPaulRyan 4 years ago
... ALL NEWS IS GOOD? ... $PEN



CNBC's Scott Wapner reports on why Quintessential Capital Management is shorting Penumbra and why it's questioning the safety of its medical devices.

👍️0
@LaughinPaulRyan @LaughinPaulRyan 4 years ago
QCM legal team filed detailed reports with allegations of misconduct with FDA, SEC and other institutions urging thorough investigation
Deceptive behavior would point to lack of integrity unworthy of management leading $10bn healthcare company and may explain Jet7 crisis leading to multiple deaths, injuries
QCM calls on Adam Elsesser, Arani Bose to resign at once if allegations confirmed
Situation constitutes existential threat to Penumbra’s viability as a public company
👍️0
@LaughinPaulRyan @LaughinPaulRyan 4 years ago
Executive Summary

Large portion of scientific literature produced by Penumbra appears authored by fake character in sophisticated, multi-year deception
Fake character seems fabricated by Penumbra’s management attempting to hide involvement in research with significant undisclosed conflicts of interest
Conflicted research used extensively to market products to healthcare providers, to support FDA applications and to promote stock in IPO
Legal advisers: behavior, if confirmed, may constitute serious fraud threatening revocation of FDA clearances, SEC enforcement and litigation from clients
👍️0
davidsson10 davidsson10 4 years ago
https://www.qcmfunds.com/penumbra-and-its-killer-catheter/?source=content_type%3Areact%7Cfirst_level_url%3Anews%7Csection%3Amain_content%7Cbutton%3Abody_link
👍️0
@LaughinPaulRyan @LaughinPaulRyan 4 years ago
... ROFLMFAO ... $PEN

Penumbra Inc
Penumbra, Inc. designs, develops, manufactures, and markets medical devices. The Company offers peripheral vascular and neurovascular devices that help patients suffering from stroke and other neurovascular diseases. Penumbra operates in the United States.
CURRENT PRICE

PEN:US197.48USD-26.54-11.85%AS OF 10:55 AM EST 12/08/2020
👍️0
TREND1 TREND1 9 years ago
IPO INFO

http://www.marketwatch.com/tools/ipo-calendar
👍️0
TREND1 TREND1 9 years ago
IPO NOW HAS SYMBOL
Penumbra PEN
👍️0
TREND1 TREND1 9 years ago
IPO should be out soon.
no symbol yet.
👍️0